355 related articles for article (PubMed ID: 24680359)
1. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
Wiegel T; Bartkowiak D; Bottke D; Bronner C; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Stöckle M; Rübe C; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hofmann R; Engenhart-Cabillic R; Hinke A; Hinkelbein W; Miller K
Eur Urol; 2014 Aug; 66(2):243-50. PubMed ID: 24680359
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Sargos P; Chabaud S; Latorzeff I; Magné N; Benyoucef A; Supiot S; Pasquier D; Abdiche MS; Gilliot O; Graff-Cailleaud P; Silva M; Bergerot P; Baumann P; Belkacemi Y; Azria D; Brihoum M; Soulié M; Richaud P
Lancet Oncol; 2020 Oct; 21(10):1341-1352. PubMed ID: 33002438
[TBL] [Abstract][Full Text] [Related]
3. Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Polat B; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Schär C; Sumila M; Zaugg K; Guckenberger M; Ost P; Reuter C; Bosetti DG; Khanfir K; Gomez S; Wust P; Thalmann GN; Aebersold DM;
Eur Urol; 2021 Sep; 80(3):306-315. PubMed ID: 34140144
[TBL] [Abstract][Full Text] [Related]
4. Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
von Hardenberg J; Cash H; Koch D; Borkowetz A; Bruendl J; Leyh-Bannurah SR; Kuru TH; Kowalewski KF; Schindele D; Mala KS; Westhoff N; Blana A; Schostak M;
World J Urol; 2021 Oct; 39(10):3747-3754. PubMed ID: 33881557
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death.
Tilki D; Chen MH; Wu J; Huland H; Graefen M; Wiegel T; Böhmer D; Mohamad O; Cowan JE; Feng FY; Carroll PR; Trock BJ; Partin AW; D'Amico AV
J Clin Oncol; 2021 Jul; 39(20):2284-2293. PubMed ID: 34086480
[TBL] [Abstract][Full Text] [Related]
6. Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC;
Eur Urol; 2020 Mar; 77(3):320-330. PubMed ID: 31771797
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?
Marvaso G; Montesano M; Corrao G; De Angelis SP; Gandini S; Mazzola GC; Augugliaro M; Franzetti J; Zerini D; Pepa M; Luzzago S; Mistretta FA; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
BJU Int; 2021 Apr; 127(4):454-462. PubMed ID: 32969548
[TBL] [Abstract][Full Text] [Related]
8. Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.
Meissner VH; Woll M; Ankerst DP; Schiele S; Gschwend JE; Herkommer K
World J Urol; 2021 Oct; 39(10):3763-3770. PubMed ID: 33973043
[TBL] [Abstract][Full Text] [Related]
9. The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.
Pascale M; Azinwi CN; Marongiu B; Pesce G; Stoffel F; Roggero E
BMC Cancer; 2017 Sep; 17(1):651. PubMed ID: 28923109
[TBL] [Abstract][Full Text] [Related]
10. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
Ranasinghe W; Shapiro DD; Hwang H; Wang X; Reichard CA; Elsheshtawi M; Achim MF; Bathala T; Tang C; Aparicio A; Tu SM; Navone N; Thompson TC; Pisters L; Troncoso P; Davis JW; Chapin BF
Eur Urol; 2021 Feb; 79(2):298-306. PubMed ID: 33279304
[TBL] [Abstract][Full Text] [Related]
11. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
Wiegel T; Albers P; Bartkowiak D; Bussar-Maatz R; Härter M; Kristiansen G; Martus P; Wellek S; Schmidberger H; Grozinger K; Renner P; Schneider F; Burmester M; Stöckle M
J Cancer Res Clin Oncol; 2021 Jan; 147(1):235-242. PubMed ID: 32886212
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on.
Segundo CG; Couñago F; Gómez-Iturriaga A
Urol Oncol; 2021 Jun; 39(6):351-356. PubMed ID: 34049780
[TBL] [Abstract][Full Text] [Related]
13. Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy.
Nicosia L; Mazzola R; Vitale C; Cuccia F; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Ruggeri R; Cavalleri S; Alongi F
Radiol Med; 2022 May; 127(5):560-570. PubMed ID: 35347581
[TBL] [Abstract][Full Text] [Related]
14. Lower Bladder Toxicity of Salvage
Vinciguerra A; Augurio A; Rosa C; Fasciolo D; Borgia M; Milone V; Marchioni M; DI Nicola M; Genovesi D; Caravatta L
In Vivo; 2022; 36(3):1375-1382. PubMed ID: 35478143
[TBL] [Abstract][Full Text] [Related]
15. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
Han JH; Herlemann A; Washington SL; Lonergan PE; Carroll PR; Cooperberg MR; Jeong CW
World J Mens Health; 2023 Oct; 41(4):940-950. PubMed ID: 37118954
[TBL] [Abstract][Full Text] [Related]
16. The clinical impact of strict criteria for active surveillance of prostate cancer in Korean population: Results from a prospective cohort.
Suh J; Yuk HD; Kang M; Tae BS; Ku JH; Kim HH; Kwak C; Jeong CW
Investig Clin Urol; 2021 Jul; 62(4):430-437. PubMed ID: 34085787
[TBL] [Abstract][Full Text] [Related]
17. Follow-up care over 12 months of patients with prostate cancer in Spain: A multicenter prospective cohort study.
Bonfill X; Martinez-Zapata MJ; Vernooij RW; Sánchez MJ; Morales-Suárez-Varela M; Emparanza JI; Ferrer M; Pijoan JI; Palou J; Madrid E; Abraira V; Zamora J;
Medicine (Baltimore); 2021 Nov; 100(47):e27801. PubMed ID: 34964747
[TBL] [Abstract][Full Text] [Related]
18. Why Do Men Reject Adjuvant Radiotherapy following Radical Prostatectomy? A Systematic Survey.
Sigg S; Arnold W; Grossmann NC; Baumeister P; Fankhauser CD; Wenzel M; Mattei A; Würnschimmel C
Urol Int; 2024; 108(3):211-218. PubMed ID: 38325350
[TBL] [Abstract][Full Text] [Related]
19. Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
Herden J; Schwarte A; Boedefeld EA; Weissbach L
Urol Int; 2021; 105(5-6):428-435. PubMed ID: 33517336
[TBL] [Abstract][Full Text] [Related]
20. Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
Zattoni F; Heidegger I; Kasivisvanathan V; Kretschmer A; Marra G; Magli A; Preisser F; Tilki D; Tsaur I; Valerio M; van den Bergh R; Kesch C; Ceci F; Fankhauser C; Gandaglia G
Front Surg; 2021; 8():691473. PubMed ID: 34307443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
